EPISODE · Aug 18, 2023 · 34 MIN
271: Racing for gene therapy, a pioneering approval, & startups in the lurch
from The Readout Loud · host STAT
Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.
Embed this episode
NOW PLAYING
271: Racing for gene therapy, a pioneering approval, & startups in the lurch
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.